Mild cognitive impairment (also known as "chemo brain" or "chemo fog") is common among individuals being treated for cancer. Recent reports suggest that up to 75% of cancer patients may experience subtle cognitive changes that make day-to-day management of work and family responsibilities very difficult. Domains affected by neurocognitive dysfunction include:
Fortunately, baseline assessments and evidence-based treatments are available to improve cognitive function.
To schedule a cognitive impairment assessment please call or email: